Save time and get answers to complex questions with AI chat
Campath litigation germany?Dabrafenib btd date 2023?When will generic fiasap insulin be available?Xiaflex market launch year?Mebendazole 100mg price?
See the DrugPatentWatch profile for Odefsey
Odefsey is the brand name of a fixed-dose HIV medicine whose generic (active ingredient) name is emtricitabine / rilpivirine / tenofovir alafenamide.[1]
Odefsey combines three active ingredients: - Emtricitabine - Rilpivirine - Tenofovir alafenamide (TAF) These are taken together as a single once-daily regimen for HIV treatment.[1]
When a product is described as a “generic Odefsey,” it typically means a version using the same active ingredients (emtricitabine/rilpivirine/tenofovir alafenamide) rather than a single different generic drug name.[1]
DrugPatentWatch.com tracks patent and generic-entry information for specific brands and their active ingredients, including Odefsey.[1] Sources 1. DrugPatentWatch.com – Odefsey (emtricitabine / rilpivirine / tenofovir alafenamide)
Other Questions About Odefsey :